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ABSTRACT 
Ezrin is member of the ERM (Ezrin-Radixin-Moesin) family of proteins that have been 
conserved through metazoan evolution.  These proteins have dormant and active forms, 
where the latter links the actin cytoskeleton to membranes.  ERM proteins have three 
domains: an N-terminal FERM (band Four-point-one ERM) domain comprising three 
subdomains (F1, F2 and F3); a helical domain; and a C-terminal actin-binding domain. In the 
dormant form, FERM and C-terminal domains form a stable complex.  We have determined 
crystal structures of the active FERM domain and the dormant FERM:C-terminal domain 
complex of human ezrin.  We observe a bistable array of phenylalanine residues in the core 
of subdomain F3 that is mobile in the active form and locked in the dormant form.  As 
subdomain F3 is pivotal in binding membrane proteins and phospholipids, these transitions 
may facilitate activation and signaling.  Full-length ezrin forms stable monomers and dimers. 
We used small-angle x-ray scattering to determine the solution structures of these species.  
As expected, the monomer shows a globular domain with a protruding helical coiled-coil.  
The dimer shows an elongated dumbbell structure that is twice as long as the monomer. By 
aligning ERM sequences spanning metazoan evolution, we show that the central helical 
region is conserved, preserving the heptad repeat.  Using this, we have built a dimer model 
where each monomer forms half of an elongated anti-parallel coiled-coil with domain-
swapped FERM:C-terminal domain complexes at each end. The model suggests that ERM 
dimers may bind to actin in a parallel fashion. 
 
SUMMARY STATEMENT 
Crystal structures of ezrin FERM and FERM:C-terminal domain complexes plus SAXS 
models for full-length ezrin monomer and dimer were elucidated.  Crystal structures show 
changes in the protein core while SAXS shows that the ezrin dimer is an elongated dumbbell.   
SHORT TITLE 
Ezrin Structure via X-ray Crystallography and SAXS 
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ABBREVIATION LIST 
ERM, ezrin-radixin-moesin; EBP50, ERM-binding-phosphoprotein 50; FERM, Four-point-
one (4.1)-ezrin-radixin-moesin; IP3, inositol-(1,4,5)-triphosphate; ICAM, intercellular 
adhesion molecule; IPTG, isopropyl -D-thiogalactopyranoside; LB, lysogeny broth media; 
NHERF, Na+/H+ exchanger regulatory factor; NEP, neutral endopeptidase; PEI, 
polyethyleneimine; PI(4,5)P2, phosphatidylinositol 4,5-biphosphate; PSGL, P-selectin 
glycoprotein ligand; RMSD, root mean square deviation; SEC, size exclusion 
chromatography; SEC-MALS, SEC coupled with in line multi angle light scattering; SEC-
SAXS, SEC coupled with small angle x-ray scattering; TEV, tobacco etch virus; MS, mass 
spectrometry. 
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INTRODUCTION  
 
 The ERM proteins: ezrin, radixin and moesin connect cell membranes and the 
underlying actin cortex [1, 2].  These three largely metazoan proteins are highly conserved 
paralogues  (human ERM proteins have overall 73-81% sequence identity). ERM proteins are 
dynamically regulated by the Rho family of small GTPases, thus, the membrane-cell cortex 
interaction can be switched on and off locally.  ERM proteins organize membrane domains 
by binding to the cytoplasmic tails of integral membrane proteins [1, 2], for example in the 
immune synapse and in vesicular trafficking, processing and phagocytosis.  The ERM protein 
ezrin is directly involved in tumor metastasis, particularly in the pediatric cancers: 
rhabdomyosarcoma and osteosarcoma [3]. 
 
Each ERM protein contains three distinct domains [4]. The first is the highly 
conserved ~300-residue FERM domain (band Four-point-one, Ezrin, Radixin, Moesin) at the 
N-terminus, which has the highest (~86%) sequence identity among the three human ERM 
proteins. The second is the intermediate or α-helical domain, which includes a proline-rich 
linker, where the latter is absent in moesin. The third domain is the C-terminal domain 
(sometimes referred to as the C-ERMAD) that shares ~71% sequence identity among human 
ERM proteins. The C-terminal domain contains a conserved phosphorylation site associated 
with activation (Thr567 in human ezrin) and a highly conserved F-actin binding sequence in 
the last 30 residues at its C-terminus [5]. 
 
The ERM proteins have at least two physiologically relevant states: the dormant or 
autoinhibited state and the active state [6]. In the dormant state, the molecules are 
biologically inert, as the functional binding sites on both the FERM domain and the 
C-terminal domain are masked by intramolecular interactions between these domains. In the 
active state, these interactions are disrupted, inducing the separation of the FERM and 
C-terminal domains. Subsequently, the FERM domain binds to the plasma membrane, while 
the C-terminal domain binds to F-actin. In the active state, the FERM domain is able to bind 
directly or indirectly (for example, through an adaptor protein EBP50/NHERF) to the 
cytoplasmic extensions of membrane proteins. It has been suggested that the last two residues 
of ezrin C-terminus are critical for interaction with both the FERM domain and the F-actin 
[6]. 
 
Studies have shown that ERM proteins are phosphorylated by Rho-kinase, protein 
kinase Cθ and protein kinase Cα. It has been proposed that the activation of ERM proteins in 
vivo occurs via a two-step mechanism [7], involving ERM proteins binding to 
phosphatidylinositol 4,5-biphosphate (PI(4,5)P2) and phosphorylation of the conserved 
threonine residue in the C-terminal domain. It has been shown that the FERM domain of 
ezrin interacts with liposomes containing PI(4,5)P2 [8]. Subsequent studies have shown that 
both phosphorylation and PI(4,5)P2 binding regulate ERM activation and thus binding to 
F-actin [9, 10].  
  
The first crystal structure of an ERM protein is that of moesin [11], comprising a 
complex between the FERM and the C-terminal domains.  Subsequent crystal structures 
include: FERM domains of ezrin [12], radixin [13] and moesin [14]; a complex between 
radixin and IP3, a mimetic of the head group of PI(4,5)P2 [13]; several complexes between 
the radixin FERM domain and peptides mimicking the cytoplasmic tails of membrane 
proteins [15-19]; and complexes of radixin with the adaptor proteins NHERF-1 and NHERF-
2 [20].  The only full-length crystal structure of an ERM protein is that of the monomeric 
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dormant state of Sfmoesin from the Fall armyworm (moth) Spodoptera frugiperda [21]. 
 
Ezrin exists in various states within cells including monomers, dimers, oligomers and 
heterodimers with other ERM proteins.  The biological significance and function of these 
species is unknown.  Gel filtration of Triton-X-100 solubilized microvilli extracts from 
human JEG-3 carcinoma cells show that ezrin is present as both a monomer and a larger 
homomeric species (possibly dimer or trimer) [22].  Two cytosolic species of ezrin have been 
purified from human placenta and have been characterized as a monomer and dimer that do 
not interconvert after isolation [23].  Solubilization of microvilli from human placenta show 
that ezrin occurs mainly as dimers and higher order oligomers [24].  These authors also show 
that stimulation of human A431 carcinoma cells with EGF induces the rapid formation of 
ezrin oligomers in vivo, which is correlated to tyrosine phosphorylation of ezrin [24].  In the 
LLC-PK1 kidney epithelial cell line, endogenous ezrin is partitioned into cytosolic and 
membrane-associated fractions where homo-oligomers (mainly dimers) make up 15 and 28%, 
respectively, of the total ezrin in each fraction [25]. In contrast, they find that endogenous  
(threonine) phosphorylated ERM proteins are largely monomeric.  Expression of wild type 
and Thr567 mutant ezrins in these cell lines supports the observation that activation of ezrin 
by phosphorylating Thr567 produces mainly monomeric ezrin [25].  Micro-injection of 
bacterially expressed human ezrin into live gastric HGT-1 cells shows that it co-
immunoprecipitates with endogenous ezrin, radixin and moesin, presumably in the form of 
homo and heterodimers [26].  Stable complexes between ezrin and moesin, presumed to be 
heterodimers, have been immunoprecipitated from human epidermoid carcinoma A431 cells 
[27].  Similarly, the ERM paralogue, merlin has been co-immunoprecipitated with ezrin from 
human U251 glioma cells, presumably as a heterodimer [28].  The above observations show 
that ezrin dimers exist in mammalian cells, however, the function of the dimer is currently 
unknown. 
   
In this paper, we present the crystal structures of the active FERM domain and the 
inactive FERM:C-terminal domain complex of human ezrin. Comparison of these two high 
resolution structures shows changes in structure and mobility that may be important in ezrin 
activation.  In particular, the hydrophobic core of subdomain F3 in the active FERM domain 
structure shows a bistable structure where an array of conserved phenylalanine residues can 
adopt two distinct arrangements. The formation of the dormant FERM:C-terminal domain 
complex stabilizes this structure by selecting one arrangement for the core phenylalanine 
residues.  We also report solution SAXS structures of full-length ezrin monomer and dimer. 
The monomer structure is consistent with the full-length Sfmoesin crystal structure where the 
central α-helical domain protrudes from the FERM domain as an elongated α-helical 
coiled-coil.  The SAXS analysis shows that the dimer is an extremely elongated dumbbell 
structure. This structure is modeled by domain-swapping, where the central α-helical 
domains from each protomer form a continuous anti-parallel coiled-coil linking the two 
domain-swapped FERM:C-terminal domain complexes. The domain-swapped nature of the 
dimer explains its stability and slow equilibration between monomer and dimer.  Sequence 
analysis shows that the heptad repeat for the entire region of the central α-helical domain 
spanned by α-helices αB and αC including the linker (helices are labeled as per the Sfmoesin 
crystal structure) is conserved throughout metazoan evolution. Thus, evolution has preserved 
the ability of ERM proteins to form the continuous, elongated coiled-coil observed in the 
dimer model. 
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MATERIALS AND METHODS 
 
Cloning 
A plasmid encoding the FERM domain of human ezrin (residues 1-296, untagged, 
35 kDa) was a gift from Mark Berryman (Ohio University, USA). Full-length human ezrin 
(residues 1-586, 69.5 kDa) was purchased from GeneArt AG, Germany, and subcloned into 
pET-15b vector (Novagen) for expression with an N-terminal His8-tag that can be removed 
by TEV cleavage.  
 
Protein Expression  
The FERM domain of ezrin was expressed in Escherichia coli strain M15(pREP4) 
(Qiagen) grown in LB media containing 100 g/ml ampicillin and 25 g/ml kanamycin at 
37 °C.  Expression was induced at mid-log growth phase with 0.1 mM IPTG at 25 °C for 9-
12 hours.  
 
Full-length ezrin was expressed in E. coli BL21(DE3) (Invitrogen) grown in LB 
media containing 100 μg/ml ampicillin at 37 °C.  Expression was induced at mid-log growth 
phase with 0.5 mM IPTG at 37 °C for three hours, producing a mixture of ezrin monomer and 
dimer. 
 
Protein purification 
Ezrin FERM domain: The FERM domain was purified using a modification of a previously 
published method [29]. The cell pellet was resuspended in lysis buffer (180 mM KH2PO4 pH 
7.0) containing protease inhibitors (Complete, EDTA-free protease inhibitor, Roche). 
Following lysis, polyethyleneimine (PEI) was added to 0.15% (v/v) after lysis to precipitate 
nucleic acids. The lysate was centrifuged at 30,000 g and the supernatant applied to a pre-
equilibrated (with lysis buffer) hydroxyapatite column at 4 °C. The protein was eluted with a 
gradient of 180 mM-900 mM KH2PO4 pH 7.0. Residual nucleic acid was removed using 
0.15% (v/v) PEI and the protein was then subjected to size-exclusion chromatography (SEC) 
on a Superdex75 column (GE Healthcare) at 4 °C in 20 mM Tris pH 8.0, 300 mM NaCl. 
After SEC, fractions containing the FERM domain were concentrated to ~12 mg/ml and 
frozen using liquid nitrogen. 
 
Full-length ezrin: The cell pellet was resuspended in 20 mM Tris pH 8.0, 500 mM NaCl, 
10 mM imidazole, 0.5 mM DTT containing protease inhibitors. After lysis, PEI was added to 
0.15% (v/v), and the lysate centrifuged at 30,000 g. Full-length ezrin was purified at room 
temperature. The clarified lysate was incubated with Ni-NTA resin (Qiagen) for 1 hour. The 
resin was washed with 20 mM Tris pH 8.0, 500 mM NaCl, 20 mM imidazole and 0.5 mM 
DTT, then protein was eluted with 20 mM Tris pH 8.0, 500 mM NaCl, 500 mM imidazole, 
0.5 mM DTT. Eluted protein was dialyzed against 20 mM Tris pH 8.0, 500 mM NaCl, 
10 mM imidazole, 1 mM DTT with a single change of dialysis solution.  The His8 tag was 
removed by incubation with His-tagged TEV protease for 16 hours.  The incubated material 
was then passed through Ni-NTA resin.  The tag-free ezrin was collected in the flow through 
and dialyzed against 20 mM Tris pH 8.5, 50 mM NaCl.  Ezrin was applied to a Q-Sepharose 
column (GE Healthcare) and eluted with 20 mM Tris pH 8.5, 145-290 mM NaCl gradient. 
The protein was further purified using a Superdex200 26/60 SEC column (GE Healthcare) in 
20 mM HEPES pH 7.0, 100 mM KCl, 1 mM DTT. This resulted in baseline separation of 
monomeric and dimeric ezrin (Fig. S1A).  Purified ezrin was concentrated and frozen in 
liquid nitrogen. 
  6 
 
Multi-Angle Light Scattering  
Molecular masses were estimated by SEC coupled with in-line multi-angle light 
scattering (SEC-MALS). SEC was via a Superose 12 10/300 GL column (GE Healthcare) in 
20 mM HEPES pH 7.0, 100 mM KCl, 1 mM DTT. The eluate was monitored by a 
miniDAWN TREOS light scattering instrument, consisting of a laser source at 690 nm and 
three discrete photodetectors (45°, 90° and 135°) coupled to an Optilab DSP differential 
refractometer (Wyatt Technology Corporation Pty Ltd). Data were collected and analyzed 
using ASTRA software, and molecular weight was calculated using a refractive index 
increment (dn/dc) value for protein of 0.19 mL/g. 
Circular Dichroism  
Circular dichroism (CD) experiments were performed using Jasco J-810 CD 
Spectropolarimeter fitted with Peltier temperature controller. Protein was diluted in 20 mM 
phosphate buffer pH 7.0 to a concentration of ~0.2 mg/ml. Spectra were collected in the far 
UV (190-260 nm) with 50 nm/minute scanning rate. The scans were repeated three times then 
averaged. CD responses were converted to mean residue ellipticity [θ] (deg cm2 dmole-1). 
Thermal denaturation experiments were performed at 208 nm with a heating rate of 
1 °C/minute between 20-80 °C. The mean residue ellipticity [θ] showed a linear dependence 
on temperature for both native/folded (N) and unfolded (U) states. Thus, the data were fit to 
two linear functions of temperature for N and U states with a sigmoidal function representing 
the unfolding transition: 
 
q[ ] =
1
1+ e
- T -TAM( ) /b
æ
èç
ö
ø÷
× Dm ×T + DC( ) + m ×T +C  
where TAM is the apparent melting temperature and b determines the steepness of the melting 
transition. The linear dependence of [θ] for N state is described by the slope m and the 
intercept C, while the linear dependence of [θ] for U state is described by the slope m+Δm 
and the intercept C+ΔC.  The thermal unfolding of all proteins tested was irreversible.  
 
Crystallization and x-ray diffraction data collection  
Crystals of the ezrin FERM domain were grown at room temperature using hanging 
drop, vapor-diffusion by mixing 2 μl protein (at ~12 mg/ml) and 2 μl of reservoir solution 
containing 0.2 M ammonium sulphate, 0.1 M HEPES pH 7.5, 10% isopropanol, 16-18% 
(w/v) PEG4000. Crystals were transferred to a cryoprotectant solution consisting of reservoir 
solution supplemented with 15% PEG400 and flash-frozen in liquid nitrogen. 
 
Crystals of the ezrin FERM:C-terminal domain complex resulted from attempts to 
crystallize monomeric and dimeric forms of full-length ezrin at room temperature using the 
hanging drop, vapor-diffusion. Crystals grew after 7-12 days in drops containing 2:1 ratio of 
protein (dimer: ~10-12 mg/ml, monomer: ~15-20 mg/ml) to reservoir solution consisting of 
0.1 M Bis-Tris pH 5.5 or pH 5.9, 15-18% (w/v) PEG3350. Crystals were transferred to a 
cryoprotectant solution consisting of reservoir solution supplemented with either 15% 
PEG400 or 15% mixture of 1:1 glycerol to 50% (w/v) PEG3350. Crystals were flash-frozen 
in liquid nitrogen.  
 
X-ray diffraction datasets for the ezrin FERM domain were collected at 100 K on an 
ADSC Quantum 210r detector installed at the Australian Synchrotron MX1 beamline.  Data 
sets for crystals grown from full-length ezrin were collected at 100 K using an ADSC 
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Quantum 315r detector at the Australian Synchrotron MX2 beamline.   Data collection was 
carried out using Blu-Ice [30]. Datasets were processed with MOSFLM [31] and scaled with 
SCALA [32]. 
 
Crystal structure determination and refinement  
Crystal structures of both the ezrin FERM domain and the ezrin FERM:C-terminal 
domain complex were solved by molecular replacement using Phaser [33]. The N-terminal 
domain of ezrin (PDB ID: 1NI2 [12]) was used as a search model for the ezrin FERM domain 
while the Sfmoesin structure (PDB ID: 2I1J [21]) was used for crystals obtained from 
full-length ezrin. Model rebuilding was carried out using COOT [34]. The overall structures 
were refined using PHENIX [35]. Water molecules were initially built using PHENIX and 
then added manually during later stages of refinement. Statistics for data reduction and 
refinement are listed in Table 1. 
 
The final model of the ezrin FERM domain contains two molecules in the asymmetric 
unit (molecule A – residues 2-296 and molecule B residues 2-137, 145-146, 150-296) with Cα 
RMSD of 0.39 Å. The main differences between the two molecules in the asymmetric unit 
are located at the flexible loop connecting α-helices α2 and α2’ in subdomain F2 (Fig. 1A). In 
molecule B, residues 138-149 are disordered with the exception of Gly145 and Tyr146. In 
both molecules, the side chain of Tyr146 forms a hydrogen bond with His176, however, the 
orientations of Gly145 and Tyr146 differ in molecules A and B.  
 
The structure of the FERM:C-terminal domain complex was determined in two 
crystal forms: space group C2221 (Ezrin-1) at 2.0 Å resolution and P21 (Ezrin-2) at 1.9 Å 
resolution.  The former was an attempt to crystallize the full-length ezrin monomer while the 
latter, the dimer.  After solving the structures, it was clear that the protein had inadvertently 
undergone limited proteolysis during crystallization.  SDS-PAGE analysis of crystals 
resolved two bands at approximately 37 kDa and 10 kDa. Mass spectrometry revealed that 
the 37 kDa band contains the FERM domain, while the 10 kDa band contains the C-terminal 
domain, residues 510-586, with molecular weight 9336.2 Da (data not shown).  Crystal 
structures in both space groups contain the FERM:C-terminal domain complex. 
 
The structure of Ezrin-1 contains one molecule in the asymmetric unit  (residues 1-
297 and 516-586), while the structure of Ezrin-2 contains two molecules in the asymmetric 
unit (molecule A: residues 1-297, 516-586 and molecule B: residues 3-297, 515-586), with 
Cα RMSD of 0.73 Å over 365 residues. There are only small differences between Ezrin-1 and 
Ezrin-2 structures with RMSDs of 0.49 Å (368 residues) and 0.73 Å (365 residues) between 
Ezrin-1 and molecules A and B of Ezrin-2, respectively.   
 
All coordinates and structure factors have been deposited with the Protein Data Bank 
with accession codes: 4RMA for the ezrin FERM domain, 4RM9 and 4RM8 for the 
FERM:C-terminal domain complexes derived from Ezrin-1 and Ezrin-2 crystals. 
 
Sequence analysis  
ERM protein sequences were obtained using the NCBI BLAST [36] server.  
Sequences were aligned using CLUSTAL W [37].  Phylogenetic trees were used to separate 
merlin protein sequences from other ERM sequences.  BLAST searches restricted by taxa 
ensured that the final sequence set had the widest possible coverage of the ERM evolutionary 
tree.   
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Small-angle x-ray scattering  
The solution structure of full-length monomeric and dimeric ezrin was determined by 
SEC coupled with SAXS (SEC-SAXS) using the SAXS/WAXS beamline at the Australian 
Synchrotron with an in-line Superose 6 PC 3.2/30 (GE Healthcare) column equilibrated with 
50 mM HEPES pH 8, 200 mM Na2SO4, 50 mM K2SO4, 5 mM β-mercaptoethanol. 50 μl of 
sample (~24 mg/ml of monomer or 10.6 mg/ml of dimer) was loaded at a flow of 0.1 ml/min, 
with the eluent flowing directly into the SAXS sample chamber (SEC chromatograms shown 
in Fig. S1B). Data were collected with using a Dectris Pilatus 1M detector at 1.13 Å 
wavelength. SEC-SAXS data were collected at sample-detector distances of 7 m and 
650 mm. 
SAXS images were taken continuously as the protein eluted from the SEC column 
(SEC chromatograms shown in Fig. S1B). Data were averaged over 2-second periods, 
reduced to 1-dimensional scattering patterns and converted to an absolute scale using the 
program Scatterbrain (written and provided by the Australian Synchrotron and available at 
http://www.synchrotron.org.au).  Useful data were obtained for Q values between 5.5×10-3 Å-
1 and 0.855 Å-1 (Q = 4p sinq /l  where l  is the wavelength and 2q is the scattering angle). 
Data were binned in groups of five consecutive 2-second frames and averaged allowing the 
radius of gyration Rg and maximum chord Dmax to be estimated.  Analysis of these Rg and 
Dmax values confirmed that the configuration of the protein was not changing over the SEC 
peak. For structure determination, only the ten brightest frames were analyzed to obtain 
maximum contrast between protein and background scattering.  Rg, Dmax and the pair distance 
distribution function P(r) were calculated using Fourier methods implemented in the program 
GNOM [38]: 
 
P r( )=
r
2π 2
Q × I Q( ) ×sin Q ×r( )dQ
0
¥
ò  
As an independent quality check, Rg was also estimated using the Guinier approximation:  
 
I Q( )= I 0( )e
-
Q2Rg
2
3  
 
Low and high Q data were merged using program PRIMUS [39] to produce final scattering 
patterns.  
 
 Ab initio methods based on a simulated annealing algorithm implemented in 
DAMMIF/DAMMIN [40] and GASBOR [41] were used to generate sets of models for both 
the ezrin monomer and dimer, using P(r) functions with input Dmax values of 172 Å and 
335 Å, respectively.  Models generated by GASBOR were favored as the program utilizes 
data over the entire Q range. A set of best models was selected for monomer and dimer based 
on c 2  with the proviso that the fit was good in the low Q region (monomer c 2  values: 0.70-
1.7; dimer c 2  values: 0.7-2.2).  These models were aligned by the DAMAVER program 
suite [42] to generate average and “filtered” (volume reduced to match expected value for 
molecule) shape functions. The program FoXS [43] was used to calculate SAXS profiles 
from atomic models.  The complete experimental data sets (Qmax=0.954Å
-1) were used to 
calculate c  values. 
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Homology Modeling  
Homology models for full-length ezrin monomer and dimer were generated by 
extending the crystal structure of the FERM:C-terminal domain complex. Sfmoesin (PDB: 
2I1J and 2I1K [21]) was used as a template. A full model for human ezrin was initially 
generated by the I-TASSER server [44]. An ideal α-helical coiled-coil region was generated 
using the CCBuilder server [45]. These two models were used to supply the missing 
segments. Splicing was carried out manually using the program COOT [34].  
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RESULTS 
Structural plasticity in the crystal structure of the ezrin FERM domain 
The crystal structure of the ezrin FERM domain (residues 1-296) was determined at 
1.75 Å resolution (Fig. 1A; Table 1) using a crystal form that is isomorphous to the 
previously reported 2.3 Å structure [12].  There are two copies of the FERM domain in the 
asymmetric unit and each molecule contains three subdomains, identified as F1 (ubiquitin 
fold), F2 (all α-helical acyl-CoA binding domain fold) and F3 (phosphotyrosine binding, 
PTB, or pleckstrin homology domain fold), respectively, forming a clover-shaped molecule 
as per all ERM FERM domains [11-14] (Fig. 1A).   
 
A distinguishing feature of this higher resolution structure of the ezrin FERM domain 
is that in one copy of the FERM domain, subdomain F3 shows two distinct conformations in 
the packing of an array of phenylalanine side chains in the core of the β-sandwich (Fig. 2A). 
Four phenylalanine residues are arrayed across the core of the outer β-sheet (β-strands β5-β7) 
of subdomain F3: Phe250 (β5), Phe255 (β6), Phe267 (β7) and Phe269 (β7). Each of these 
phenylalanine residues can adopt one of two rotamer conformations (cyan and magenta in 
Fig. 2A).  In the two conformations of the phenylalanine array in subdomain F3, each 
phenylalanine side chain points in the same direction like a stack of dominos.  To alternate 
between configurations, each side chain must switch rotamer in concert with the others (Fig. 
2A).  The refinement of the structure indicates that these conformations are equally populated 
in one copy of the FERM domain (molecule A, Fig. 2A), while the other copy (molecule B, 
Fig. 2B) shows only one conformation which is similar to the one seen in most other ERM 
structures (see Discussion for exceptions). 
 
The flexibility of the outer β-sheet region of subdomain F3, containing β-strands β5, 
β6 and β7 (Figs 1A, 2A and 2B), is reflected in the elevated B-factors for this region in both 
copies of the structure in the asymmetric unit (Fig. 2D), as shown previously [12].  The main 
chain B-factors of β-strands β5-β7 are 20-30 Å2 higher than either the overall FERM domain 
or subdomain F3 (Fig. 2E). 
 
Crystal structures of the ezrin FERM:C-terminal domain complex obtained by 
crystallizing purified monomer and dimer samples 
Crystals were obtained from both purified full-length ezrin monomer and dimer.  The 
structures determined from these crystals were essentially identical, showing complexes 
between the FERM domain and the C-terminal domain with no density (or room) for the 
central helical domain.  SDS-PAGE and mass spectrometry confirmed that limited 
proteolysis had occurred during crystallization (see Methods). 
 
The crystal structure of the complex between the FERM domain and the C-terminal 
domain was determined in two different space groups at 1.9 Å (dimer sample) and 2.0 Å 
(monomer sample) resolutions, respectively (Figs 1B and 1C, Table 1).  These structures 
show the C-terminal domain (residues 516-586) is intimately wrapped around the FERM 
domain (residues 1-297) as seen in the previously reported structures of dormant ERMs [11, 
21].  The C-terminal domain is composed of four α-helices: α1C-α4C (Fig. 1B). 
 
The only difference between structures of the ezrin FERM:C-terminal domain 
complex are the proximity of subdomain F1 to subdomain F3 (Fig. 1C).  The largest 
difference can be seen on comparing the two molecules in the asymmetric unit of 4RM8 (Fig. 
1C, green and purple), where the separation between the subdomains is closer by about 1-2 Å 
in molecule B, which has lower overall B-factors. 
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The fact that crystals obtained from both purified monomer and dimer samples 
resulted in the same structure after limited proteolysis suggests that this structure is present in 
both forms of the protein. 
 
Structural changes in the FERM domain on binding the C-terminal domain 
There are no major changes in the structure of the FERM domain of ezrin on forming 
a complex with the C-terminal domain (Cα RMSDs of 0.93-1.3 Å between FERM only and 
FERM:C-terminal domain complexes compared with Cα RMSDs of 0.49-0.73 Å among the 
complexes).  However, there are specific regions in the FERM domain where the binding of 
the C-terminal domain alters the structure (Fig. 1D). 
 
As noted from the radixin FERM domain structure [13], binding of the C-terminal 
domain alters the structure of the outer β-sheet (β-strands β5, β6 and β7) of subdomain F3 
(Fig. 1D), the region showing plasticity in the FERM only structure.  These three β-strands 
translate by approximately 3 Å towards subdomain F1 on binding C-terminal domain (Fig. 
1E).  Large changes are seen in the loop connecting β-strands β6 and β7, which is directly 
adjacent to helix α4C in the C-terminal domain (Fig. 1E).   
 
Binding of the C-terminal domain to subdomain F3 stabilizes its plastic hydrophobic 
core structure.  The binding of α-helix α4C positions the side chain of Phe583 so that it 
selects only one possible conformation for the four phenylalanine residues (Phe267, Phe269, 
Phe255 and Phe250) that form the phenylalanine domino array in the core of subdomain F3 
(Fig. 2C).  This stabilization of the F3 core results in a reduction of the main chain B-factors 
for the outer β-sheet (β-strands β5-β7) so that they are within ~10 Å2 of the remainder of the 
structure  (Fig. 2F).   
 
Ezrin FERM subdomain F2 is an all α-helical structure (helices α1, α2, α2’, α3 and 
α4; Fig. 1).  The binding of the C-terminal domain results in the rotation of helices α2’ and 
α3 and changes in the long loop connecting helices α2 to α2’ (Fig. 1F), while helices α1, α2 
and α4 make only small movements.  These changes in FERM subdomain F2 accommodate 
the binding of helix α1C and the loop connecting it to α2C in the C-terminal domain. These 
changes are consistent with those seen on comparing the FERM domain structures of radixin 
[13] and moesin [14] to the moesin FERM:C-terminal domain complex [11]. 
 
Multi-angle light scattering shows bacterially expressed ezrin forms stable monomer 
and dimer fractions 
The expression of full-length ezrin in E. coli results in two fractions that can be 
separated by SEC that are called monomer and dimer (Fig. S1A).  To confirm that these SEC 
peaks actually correspond to ezrin monomer and dimer species, we performed multi-angle 
light scattering in-line with the SEC column (SEC-MALS).  The estimated molecular masses 
of the monomer and dimer peaks were 70,800±900 Da and 140,000±2,000 Da, respectively.  
These are consistent with the calculated molecular masses of monomer and dimer (69,470 Da 
for 586 residue monomer plus N-terminal glycine).  Recycling either monomer or dimer 
fraction through the SEC column did not result in re-equilibration of the protein into 
monomer and dimer (data not shown).  Thus, both monomer and dimer are stable under the 
conditions of the experiment. 
 
Thermal stability of ezrin as measured by circular dichroism 
Figure 3A shows the far UV circular dichroism (CD) spectra of the ezrin FERM 
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domain and the monomeric and dimeric forms of full-length WT ezrin before (at 20 °C) and 
after thermal denaturation (at 80 °C). The thermal unfolding transition is not reversible.  
Figure 3B shows the mean residue ellipticity [θ] at 208 nm as a function of temperature for 
all proteins studied.  They all show a clear unfolding transition.  By fitting these curves with a 
sigmoidal function, we obtained the apparent melting temperatures, TAM, for each protein 
(Fig. 3B).  The data show that the full-length structures are significantly more stable than the 
isolated FERM domain (TAM of 44.8±0.1°C for the FERM only, compared to 65.0±1.2 and 
66.2±1.1°C for full-length monomer and dimer, respectively).  The apparent melting 
temperatures of monomer and dimer species are indistinguishable.  We note that prior to the 
sigmoidal unfolding transition, the mean residue ellipticity shows a linear dependence on 
temperature for both full-length monomer and dimer samples.  Such a linear dependence on 
temperature is typical for coiled-coil proteins [46] as well as stable single α-helices [47]. 
 
Solution structure of full-length ezrin monomer and dimer by SAXS 
In order to gain insight into the structure of full-length ezrin, we collected small-angle 
x-ray scattering (SAXS) data in-line with a SEC column on previously purified monomer and 
dimer (Fig. 4; Table 2).  The scattering curves for the monomer and dimer are almost 
indistinguishable except at very small angles (scattering vector magnitude Q<0.1 Å-1 
corresponding to Bragg spacing of D>63 Å).  At very low angles (Q<0.02 Å-1, D>314 Å), the 
dimer scattering increases more rapidly than the monomer, as would be expected for a larger 
molecule (Fig. 4A plus inset).  For Q values between 0.02 and 0.06 Å-1 (D=314 Å and 105 Å, 
respectively), damped oscillations are observed in the difference between the monomer and 
dimer scattering (Fig. 4A inset).  We note that a previous study failed to distinguish between 
the ezrin monomer and dimer via SAXS [48].  The reason for this appears to be the Q ranged 
used in the previous study, which had a lower limit of 0.014 Å-1 and hence the key difference 
between monomer and dimer SAXS (the upsweep below 0.02 Å-1) is effectively missing in 
their data. 
 
Guinier (Fig. 4B inset) and P(r) analysis (Fig. 4C) of the data are consistent with each 
other, giving the following structural parameters for the monomer: radius of gyration, 
Rg=40±1 Å and maximal chord, Dmax=165±5 Å; and dimer: Rg=95±5 Å and Dmax=325±5 Å 
(Table 2).  The Dmax values suggest that the ezrin dimer is twice as long as the monomer.   
 
The P(r) plot for the monomer SAXS data shows a single peak around 35Å with an 
elongated tail at large pair distances (Fig. 4C).  In contrast, the P(r) plot for the dimer shows 
two peaks, one around a pair distance of 35 Å that corresponds to the monomer peak and a 
second, at a pair distance around 210 Å (Fig. 4C).  The pair distribution for the dimer data is 
characteristic of a dumbbell-shaped protein. 
 
Molecular models for the ezrin monomer  
Ab initio models for the ezrin monomer using the SAXS data consistently resulted in 
comma shaped molecules (Fig. 5A).  Given the similarity between these models and the 
crystal structure of full-length Sfmoesin [21], we used this structure combined with our 
crystal structure to build a complete homology model of human ezrin (Fig. 5B).  Modeling 
the central helical domain as an extended coiled-coil is consistent with the experimentally 
determined maximum chord, Dmax, of 165±5 Å for the ezrin monomer. The monomer model 
was docked into the envelope of the averaged (Fig. 5B, grey) and filtered (Fig. 5B, green) 
shapes generated from the family of ab initio SAXS models.  Although the homology model 
fits the SAXS envelope, we stress that SAXS is a low-resolution technique, thus, the 
envelope equally fits a family of models where the globular domain is rotated with respect to 
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the coiled-coil. 
 
Low resolution/SAXS models for the ezrin dimer  
Ab initio models of the ezrin dimer using SAXS data produce very elongated 
structures (Fig. 5C).  Each model has two globular regions at the extremities linked by a 
thinner connecting region.  The panel of model structures shows that the ezrin dimer is 
extremely elongated with the separation between the globular structures conserved between 
models. 
 
Analysis of the SAXS data shows that the maximum chord, Dmax, for the dimer is 
twice that of the monomer. Additionally, the P(r) plot shows that the ezrin dimer is a 
dumbbell shaped molecule.  The simplest way to fulfill these two constraints is to dock two 
ezrin monomers so that their coiled-coil arms align tip to tip so as to resemble a single coiled-
coil of double the monomer length.  Such a model places the two FERM:C-terminal domain 
complexes at opposite ends of the central coiled-coil producing a dumbbell-shaped molecule.  
The only problem with this model is that such a dimer would be highly unstable if the only 
dimer contact was via the very tip of the coiled-coil (i.e. not a domain swapped dimer). 
 
Sequence analysis of the central α-helical domain  
To determine the role of the central α-helical domain in dimer formation, we analyzed 
a wide range of ERM protein sequences.  A BLAST [36] search of the non-redundant protein 
sequence database (NCBI) showed that ERM proteins are present in nearly all metazoa.  
Alignment of representative ERM protein sequences spanning the metazoan evolutionary tree 
shows that ERM proteins are highly conserved with many residues in the FERM and C-
terminal domains invariant.   
 
We examined the conservation of the central α-helical domain (Fig. S2).  The crystal 
structure of the full-length ERM monomer, Sfmoesin, was used to identify the three α-helices 
in the α-helical domain (αA, αB and αC, Fig. S2).  The sequence of the N-terminus of the 
first helix, αA, is highly conserved.  The length of the second α-helix, αB, appears to be 
conserved with the caveat that, in chordates, it appears to be longer by seven residues due to 
an insertion near its N-terminus. This insertion appears to have occurred during chordate 
evolution, as it is present in the ERM protein from the tunicate Ciona intestinalis (Fig. S2).  
The region between the C-terminus of α-helix αC and the C-terminal domain is poorly 
conserved in terms of residue identity and sequence length. Additionally, it contains low-
complexity sequences. 
 
Although the sequences of helices αB and αC are not conserved, the heptad repeat, 
which is a signature of coiled-coil structures [49], is conserved in these helices (Fig. S2).  
This can be seen in the pattern of hydrophobic residues at the ‘a’ and ‘d’ positions in the 
heptad repeat (highlighted in yellow in Fig. S2).  More importantly, the length of the linker 
between α-helices αB and αC (as seen in the Sfmoesin crystal structure) is conserved [21].  
The length of this linker is such that it preserves the register of the heptad repeat of the 
coiled-coil when the sequence is extended into one long α helix (Fig. S2).  This has been 
noted previously, based on the alignment of the Sfmoesin sequence with the human ERM-
merlin sequences [21]. By aligning ERM proteins spanning metazoa we see that the register 
of the heptad repeat is conserved throughout metazoan evolution (Fig. S2). 
 
In order to accommodate both the monomer and dimer forms, the linker between 
helices αB and αC must be able to adopt two conformations, a loop and a helical coiled-coil, 
  14 
respectively.  In this regard, we note that the residues in the heptad ‘d’ and ‘a’ positions in 
this loop (residues numbered 112 and 116 in Fig. S2) are not hydrophobic, however, they are 
observed in these core positions in two-helix antiparallel coiled-coils.  In the vertebrate 
sequences (Fig. S2), these two positions are occupied by glutamine residues (with one 
exception: arginine at position ‘a’ in Callorhinchus milii (elephant shark) sequence). In lower 
order metazoa, the ‘d’ site (residue 112) is occupied by: Glu (6), Thr (2), Asp or Ser while the 
‘a’ site (residue 116) is occupied by: Lys (6), Arg (3) or Leu.  Using the CC+ relational 
database of coiled-coil structures [50], we find that the Swiss-Prot normalized propensities in 
two-helix antiparallel coiled-coils for the ‘d’ site are: Gln 0.59, Glu 0.76, Thr 0.62, Asp 0.21 
and Ser 0.52; while for the ‘a’ site they are: Gln 1.0, Lys 0.73, Arg 0.86 and Leu 2.66.  Thus, 
these residues are not rare at these core positions in two-helix antiparallel coiled-coils.  
Therefore, the link between αB and αC is consistent with a metamorphic structure that can 
switch between a loop and a coiled-coil. 
 
The conservation pattern of the central α-helical domain has several implications for 
ERM proteins.  First, the preservation of the heptad repeat register through the sequence 
connecting α-helices αB and αC indicates that the monomer structure can be opened up to 
form a domain-swapped dimer where α-helices αB and αC form one, continuous α-helix that 
makes up half of a coiled-coil.  Second, the conservation of the length of α-helices αB and αC 
(apart from a possible seven residue insertion in chordates) indicates that the coiled-coil 
domain serves a biological function.   
 
Molecular models for the ezrin dimer  
Given the sequence conservation in the central α-helical domain, we used the model 
of the ezrin monomer to build a model for the dimer where the coiled-coil is extended to form 
an elongated dumbbell (Fig. 5D, cartoon).  This domain-swapped model satisfies the 
requirement of doubling the maximum chord, Dmax, of the monomer.  The model matches the 
averaged (Fig. 5D, grey) and filtered (Fig. 5D, green) shapes generated from the family of ab 
initio SAXS models.  As per the monomer, SAXS is a low-resolution technique, hence, 
rotation of the globular domains relative to the coiled-coil will not affect the match between 
homology model and the SAXS shapes. 
 
The fact that the monomer and dimer SAXS profiles are nearly identical except for 
very low angles supports the domain-swapped dimer model, as it indicates that the structural 
features of the dimer are identical to those of the monomer except at very long length scales.  
Given the crystallographic evidence for a coiled-coil in the monomer [21], the high 
correspondence between the monomer and dimer SAXS data argues that the same coiled-coil 
structure has to be present in the dimer. 
 
Evaluation of the molecular models against the SAXS data  
SAXS is a low-resolution technique, hence it is problematic to refine atomic models 
against SAXS data.  However, SAX data should be able to select between competing putative 
atomic models.  To evaluate atomic models, the program FoXS was used which generates a 
SAXS profile by evaluating the Debye equation [43].  The program outputs a χ value as a 
measure of quality of fit.  The full homology models for the monomer and dimer resulted in χ 
values of 3.92 and 4.45 (Table 3) suggesting that portions of the model are incorrect.  Given 
this, we created a series of partial models for both monomer and dimer, starting with the 
crystal structure of the FERM:C-terminal domain complex, which is a true atomic structure, 
and increasing the completeness of the models in a stepwise fashion by adding segments 
starting with those with the highest confidence (Fig. S3A).   
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For the monomer, the crystal structure alone gives a poor fit to the data (χ value 
12.99, Table 3).  Using the crystal structure of Sfmoesin as a guide, an ideal coiled-coil was 
added to the crystal structure, reducing the χ value to 4.12.  Connecting the N-terminus of the 
coiled-coil to the FERM domain by adding helix αA and completing the N-terminus of helix 
αB further decreased the χ value to 2.26, which is a reasonable value for a single atomic 
model missing 7% of the structure [43].  The calculated SAXS profile for this model is 
shown in Fig. S3B along with the experimental profile.  Further extension of the model 
reduced the quality of the fit (increased the χ value, Table 3).  These segments of the model 
are likely to be poor as the sequence of human ezrin diverges from Sfmoesin, which is the 
template for building the model.  They include the proline rich segment at the C-terminus of 
the helical domain. 
 
The above set of partial ezrin monomer models were used to generate dimer models 
via domain swapping as described above.  For the dimer models, the lowest χ value was 
observed for a model comprising only the two copies of the crystal structure plus the coiled-
coil (χ value 3.19, Table 3). This is a reasonable χ value for model comprising 83% of the 
scattering mass [43].  Connecting the FERM domain to the coiled-coil domain increased the χ 
value to 3.58, in contrast to the reduction observed in the monomer model (Table 3).  This 
suggests that either the orientations of the two globular domains of the dumbbell may be mis-
oriented or there exists some degree of flexibility in the coiled-coil, preventing a single model 
fitting the data.  The calculated SAXS profile for the dimer model where the FERM domain 
is connected to the coiled-coil via helix αA (equivalent to the best monomer model) is 
compared to the data in Fig. S3C. 
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DISCUSSION 
The ERM proteins form a nexus between cell membranes and the underlying cortical 
actin cytoskeleton.  As such, they must integrate signals from several sources and transmit 
information.  To achieve this, the ERM proteins have several distinct structural states, 
dormant and activated, and appear to utilize higher order complexes including dimers.  The 
results of our structural studies uncover potential mechanisms by which the ERM protein 
ezrin may transmit information between binding sites.  Our SAXS-based structure for the 
ezrin dimer suggests a model for how ERM proteins couple membranes to F-actin so as to 
maintain the cortical actin cytoskeleton parallel to the membrane. 
 
 The FERM only crystal structure represents the activated FERM domain.  Our key 
finding is that the hydrophobic core of subdomain F3 displays a bistable structure where a 
row of phenylalanine residues can adopt one of two mutually exclusive configurations (Fig. 
2A).  We are not aware of any other protein structure that displays such a dramatic bistability 
in its hydrophobic core.  The core bistability is consistent with the thermal stability data (Fig. 
3) and the elevated B-factors (noted previously [12]; Fig. 2E). 
 
 The crystal structure of the FERM:C-terminal domain complex represents the 
dormant form.  The binding of α-helix α4C from the C-terminal domain to the edge of 
subdomain F3 inserts the side chain of Phe583 into the hydrophobic core of subdomain F3.  
This selects a single arrangement of the core phenylalanine array (Fig. 2C) acting as a 
keystone [12] stabilizing the structure (Figs 2C, 2F).  The binding of the adaptor proteins 
NHERF-1/EBP50 and NHERF-2 stabilizes subdomain F3 via the same mechanism [20]. 
 
 The bistable structure of the core phenylalanine array may transmit information 
between functional sites on subdomain F3.  This subdomain has three interaction sites: the 
opening between the two β-sheets adjacent to β-strand β7 and β4 where the C-terminal 
domain or NHERF adaptors bind; the opposite edge of the outer β-sheet (proximal to β-strand 
β5) where cytoplasmic domains of membrane proteins bind [15-19]; and the outer surface of 
the subdomain F3 β-sandwich (β-strands β5, β6 and β7) which is likely to be important in 
membrane binding. Thus, the core phenylalanine array in subdomain F3 may be involved in 
integrating information among these sites.   
 
 An examination of these core phenylalanine residues in all available ERM structures 
shows that, in general, the phenylalanine side chains adopt the same rotamers as seen in the 
dormant structure.  The only exceptions are radixin FERM domain bound to the cytoplasmic 
domain of CD44 [16] and one molecule in the radixin FERM domain dimer [51].  In both of 
these structures, a peptide forms an additional anti-parallel β-strand that binds to β5 of 
subdomain F3. However, in most structures of complexes between the radixin FERM domain 
and peptides representing membrane protein cytoplasmic domains, the rotamer conformation 
of the core phenylalanine array is identical to the dormant structure [15, 17-19]. 
 
 The precise role of the central α-helical domain in ERM proteins is enigmatic.  
Models for the coupling of membranes to F-actin by ERM proteins show a membrane-bound 
FERM domain linked to an F-actin bound C-terminal domain via an extended central domain 
[2].  Studies on the isolated α-helical domain from radixin indicate that it may form a 
monomeric stable α-helix [52].  However, the crystal structure of Sfmoesin shows that a large 
portion of the α-helical domain forms a coiled-coil with a conserved heptad repeat [21].  
Thus, if in the activated state, the FERM and C-terminal domains were to be separated by 
either an extended stable α-helix or an unstructured chain, a significant hydrophobic surface 
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would be exposed, rendering the structure unstable. 
 
 A more likely scenario is that ERM proteins maintain a coiled-coil structure in the 
central α-helical domain.  Our CD thermal denaturation experiments on full length ezrin 
show a linear dependence on temperature prior to unfolding (Fig. 3B),which is typical for 
coiled-coils [46], however, it does not exclude single, stable α-helices [47].  
 
 The SAXS data shows that the full-length, dormant ezrin monomer structure 
resembles that of Sfmoesin [21].  A similar result has been obtained via small-angle neutron 
scattering (SANS) using deuterated ezrin [48]. Thus, the central α-helical domain forms a 
coiled-coil that extends from the FERM domain which is consistent with SAXS and CD data. 
 
 Alignment of ERM protein sequences spanning metazoa shows that several features 
of the central α-helical domain are conserved.  As noted previously, the heptad repeat is 
conserved which is consistent with the coiled-coil observed in the dormant state mononmer 
structure [21].  Additionally, the length of the region linking the two α-helices (αB and αC) in 
the coiled-coil structure is conserved (Fig. S2).  More importantly, the length of this linker 
preserves the phase of the heptad repeat between the two α-helices.  This is a striking feature 
to conserve in the central α-helical domain over the whole of metazoan evolution.  It is 
important for understanding the nature of the ERM dimer states. 
 
 In our model for the dimer, the monomer structure is opened up at the linker region 
connecting α-helices αB and αC of the coiled-coil. Because the linker preserves the phase of 
the heptad repeat, ezrin is able to form a continuous coiled-coil of twice the monomer length 
resulting in a domain-swapped dimer.  This model is consistent with previous work and it 
explains previous results.  The first detailed characterization of the ezrin dimer using SEC 
and analytical ultracentrifugation ascertained that the dimer was a stable, elongated species 
with little exchange between species [23]. The domain-swapped nature of our dimer model 
explains why monomer and dimer fractions do not exchange as this would require the 
complete unfolding of the elongated coiled-coil which is stabilized by a large hydrophobic 
interface. 
 
 Several studies have revealed structures for what is likely to be the dimeric state of 
ERM proteins.  Low-angle rotary shadowing electron microscopy revealed two forms of 
radixin, one predominantly in samples of wild type and the phospho-resistant T564A, which 
shows a globular protein, consistent with the dormant monomer structure, while the 
phosphomimetic T564E showed a large fraction of elongated dumbbell molecules [53].  
Although these were originally thought to be open monomers, their properties are consistent 
with our dimer model.   
 
 The dimer model is also consistent with images of ezrin obtained by atomic force 
microscopy (AFM) [54].  These authors collected images on bacterially-expressed wild type, 
T567A and T567D ezrin.  The images show both globular structures resembling the dormant 
monomer and several types of dumbbell structures.  The authors interpret the dumbbell 
structures as open and half-closed monomers, however, the images are consistent with our 
dimer model.  We note that the AFM images also show higher order structures. 
 
 The conservation of the linker between the two coiled-coil helices in the monomer 
structure so as to maintain the phase of the heptad repeat indicates that evolution has 
preserved the ability of ERM proteins to form elongated domain-swapped dimer structures as 
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per our dimer model.  This suggests that the ERM dimer plays a functional role in biology.  
The dimer structure places the two principal ERM functionalities, binding to membranes and 
binding to F-actin, at both ends of an elongated dumbbell.  Thus, the dimer may bind along 
the axis of an actin filament.  We speculate that such a structure may naturally link F-actin to 
a membrane so that the filaments lie parallel to the membrane surface.   
 
  19 
 
 
ACKNOWLEDGEMENTS  
This research was undertaken on the MX1, MX2 and SAXS/WAXS beamlines at the 
Australian Synchrotron, Victoria, Australia.  SAXS experiments were carried out with the 
assistance of Nigel Kirby and Haydyn Mertens of the Australian Synchrotron.  We thank 
Mark Berryman for the plasmid encoding the ezrin FERM domain, Robert Knott for 
assistance with preliminary SAXS measurements using the ANSTO Bruker NanoStar, Dek 
Woolfson for input regarding coiled-coils, Joel Mackay for the usage of MALS equipment 
and Sam Breit, Louise Brown, Katharine Michie, Sophia Goodchild, Till Böcking, Peter 
Gunning and Thomas Huber for fruitful discussions. MS analysis was supported by access to 
the University of Sydney’s Mass Spectrometry Core Facility. 
 
 
DECLARATION OF INTEREST  
The authors declare that they have no conflicts of interest with the contents of this article.  
 
 
FUNDING 
This research was supported under the Australian National Health and Medical Research 
Council Project Grant scheme (APP1085718). J.M.P. was supported by an Australian 
Nuclear Science and Technology Organisation (ANSTO) Postgraduate Scholarship.  
 
 
AUTHOR CONTRIBUTIONS  
JMP, KEW, APD and PMGC conceived and coordinated the study and wrote the paper.  JMP 
purified all proteins.  RBD performed all molecular biology tasks. JMP and SJH determined 
the crystal structures.  APD, AVS and SAB collected SAXS data.  APD, AVS, JCW and 
PMGC analyzed SAXS data. BC performed MS. CDN performed MALS experiments.  JMP 
performed and analyzed CD.  CG initiated experiments on FERM.  EHCB and PMGC 
analyzed the coiled-coil region.  All authors reviewed the results and approved the final 
version of the manuscript. 
 
  20 
REFERENCES 
1 Neisch, A. L. and Fehon, R. G. (2011) Ezrin, Radixin and Moesin: key regulators of 
membrane-cortex interactions and signaling. Curr. Opin. Cell Biol. 23, 377-382 
2 Fehon, R. G., McClatchey, A. I. and Bretscher, A. (2010) Organizing the cell cortex: 
the role of ERM proteins. Nat. Rev. Mol. Cell. Biol. 11, 276-287 
3 Clucas, J. and Valderrama, F. (2014) ERM proteins in cancer progression. J Cell Sci. 
127, 267-275 
4 Bretscher, A., Chambers, D., Nguyen, R. and Reczek, D. (2000) ERM-Merlin and 
EBP50 protein families in plasma membrane organization and function. Annu. Rev. Cell 
Dev. Biol. 16, 113-143 
5 Turunen, O., Wahlstrom, T. and Vaheri, A. (1994) Ezrin has a COOH-terminal actin-
binding site that is conserved in the ezrin protein family. J. Cell Biol. 126, 1445-1453 
6 Gary, R. and Bretscher, A. (1995) Ezrin self-association involves binding of an N-
terminal domain to a normally masked C-terminal domain that includes the F-actin binding 
site. Mol. Biol. Cell. 6, 1061-1075 
7 Fievet, B. T., Gautreau, A., Roy, C., Del Maestro, L., Mangeat, P., Louvard, D. and 
Arpin, M. (2004) Phosphoinositide binding and phosphorylation act sequentially in the 
activation mechanism of ezrin. J. Cell Biol. 164, 653-659 
8 Niggli, V., Andreoli, C., Roy, C. and Mangeat, P. (1995) Identification of a 
phosphatidylinositol-4,5-bisphosphate-binding domain in the N-terminal region of ezrin. 
FEBS Lett. 376, 172-176 
9 Nakamura, F., Huang, L., Pestonjamasp, K., Luna, E. J. and Furthmayr, H. (1999) 
Regulation of F-actin binding to platelet moesin in vitro by both phosphorylation of threonine 
558 and polyphosphatidylinositides. Mol. Biol. Cell. 10, 2669-2685 
10 Yonemura, S., Matsui, T. and Tsukita, S. (2002) Rho-dependent and -independent 
activation mechanisms of ezrin/radixin/moesin proteins: an essential role for 
polyphosphoinositides in vivo. J. Cell Sci. 115, 2569-2580 
11 Pearson, M. A., Reczek, D., Bretscher, A. and Karplus, P. A. (2000) Structure of the 
ERM protein moesin reveals the FERM domain fold masked by an extended actin binding 
tail domain. Cell. 101, 259-270 
12 Smith, W. J., Nassar, N., Bretscher, A., Cerione, R. A. and Karplus, P. A. (2003) 
Structure of the active N-terminal domain of Ezrin. Conformational and mobility changes 
identify keystone interactions. J. Biol. Chem. 278, 4949-4956 
13 Hamada, K., Shimizu, T., Matsui, T., Tsukita, S. and Hakoshima, T. (2000) Structural 
basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain. 
EMBO J. 19, 4449-4462 
14 Edwards, S. D. and Keep, N. H. (2001) The 2.7 A crystal structure of the activated 
FERM domain of moesin: an analysis of structural changes on activation. Biochemistry. 40, 
7061-7068 
15 Takai, Y., Kitano, K., Terawaki, S., Maesaki, R. and Hakoshima, T. (2008) Structural 
basis of the cytoplasmic tail of adhesion molecule CD43 and its binding to ERM proteins. J. 
Mol. Biol. 381, 634-644 
16 Mori, T., Kitano, K., Terawaki, S., Maesaki, R., Fukami, Y. and Hakoshima, T. 
  21 
(2008) Structural basis for CD44 recognition by ERM proteins. J. Biol. Chem. 283, 29602-
29612 
17 Terawaki, S., Kitano, K. and Hakoshima, T. (2007) Structural basis for type II 
membrane protein binding by ERM proteins revealed by the radixin-neutral endopeptidase 
24.11 (NEP) complex. J. Biol. Chem. 282, 19854-19862 
18 Takai, Y., Kitano, K., Terawaki, S., Maesaki, R. and Hakoshima, T. (2007) Structural 
basis of PSGL-1 binding to ERM proteins. Genes Cells. 12, 1329-1338 
19 Hamada, K., Shimizu, T., Yonemura, S., Tsukita, S. and Hakoshima, T. (2003) 
Structural basis of adhesion-molecule recognition by ERM proteins revealed by the crystal 
structure of the radixin-ICAM-2 complex. EMBO J. 22, 502-514 
20 Terawaki, S., Maesaki, R. and Hakoshima, T. (2006) Structural basis for NHERF 
recognition by ERM proteins. Structure. 14, 777-789 
21 Li, Q., Nance, M. R., Kulikauskas, R., Nyberg, K., Fehon, R., Karplus, P. A., 
Bretscher, A. and Tesmer, J. J. (2007) Self-masking in an intact ERM-merlin protein: an 
active role for the central alpha-helical domain. J. Mol. Biol. 365, 1446-1459 
22 Pakkanen, R. and Vaheri, A. (1989) Cytovillin and other microvillar proteins of 
human choriocarcinoma cells. J. Cell. Biochem. 41, 1-12 
23 Bretscher, A., Gary, R. and Berryman, M. (1995) Soluble ezrin purified from placenta 
exists as stable monomers and elongated dimers with masked C-terminal ezrin-radixin-
moesin association domains. Biochemistry. 34, 16830-16837 
24 Berryman, M., Gary, R. and Bretscher, A. (1995) Ezrin oligomers are major 
cytoskeletal components of placental microvilli: a proposal for their involvement in cortical 
morphogenesis. J. Cell Biol. 131, 1231-1242 
25 Gautreau, A., Louvard, D. and Arpin, M. (2000) Morphogenic effects of ezrin require 
a phosphorylation-induced transition from oligomers to monomers at the plasma membrane. 
J. Cell Biol. 150, 193-203 
26 Andreoli, C., Martin, M., Le Borgne, R., Reggio, H. and Mangeat, P. (1994) Ezrin has 
properties to self-associate at the plasma membrane. J. Cell Sci. 107 ( Pt 9), 2509-2521 
27 Gary, R. and Bretscher, A. (1993) Heterotypic and homotypic associations between 
ezrin and moesin, two putative membrane-cytoskeletal linking proteins. Proc. Natl Acad. Sci. 
U. S. A. 90, 10846-10850 
28 Gronholm, M., Sainio, M., Zhao, F., Heiska, L., Vaheri, A. and Carpen, O. (1999) 
Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein 
merlin and the ERM protein ezrin. J. Cell Sci. 112 ( Pt 6), 895-904 
29 Smith, W. J. and Cerione, R. A. (2002) Crystallization and preliminary 
crystallographic analysis of the ezrin FERM domain. Acta Crystallogr. D Biol. Crystallogr. 
58, 1359-1361 
30 McPhillips, T. M., McPhillips, S. E., Chiu, H. J., Cohen, A. E., Deacon, A. M., Ellis, 
P. J., Garman, E., Gonzalez, A., Sauter, N. K., Phizackerley, R. P., Soltis, S. M. and Kuhn, P. 
(2002) Blu-Ice and the Distributed Control System: software for data acquisition and 
instrument control at macromolecular crystallography beamlines. J. Synchrotron Radiat. 9, 
401-406 
31 Leslie, A. G. W. (1992) Recent changes to the MOSFLM package for processing film 
and image plate data. Joint CCP4 + ESF-EAMCB News-letter of Protein Crystallography, 
  22 
No. 26. CCP4, CCLRC Daresbury Laboratory, Cheshire, UK. 
32 COLLABORATIVE COMPUTATIONAL PROJECT No. 4 (1994) The CCP4 Suite: 
Programs for Protein Crystallography. Acta Crystallogr. D Biol. Crystallogr. 50, 760-763 
33 McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C. 
and Read, R. J. (2007) Phaser crystallographic software. J. Appl. Crystallogr. 40, 658-674 
34 Emsley, P., Lohkamp, B., Scott, W. G. and Cowtan, K. (2010) Features and 
development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486-501 
35 Adams, P. D., Afonine, P. V., Bunkoczi, G., Chen, V. B., Davis, I. W., Echols, N., 
Headd, J. J., Hung, L. W., Kapral, G. J., Grosse-Kunstleve, R. W., McCoy, A. J., Moriarty, 
N. W., Oeffner, R., Read, R. J., Richardson, D. C., Richardson, J. S., Terwilliger, T. C. and 
Zwart, P. H. (2010) PHENIX: a comprehensive Python-based system for macromolecular 
structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213-221 
36 Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W. and 
Lipman, D. J. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database 
search programs. Nucleic Acids Res. 25, 3389-3402 
37 Thompson, J. D., Higgins, D. G. and Gibson, T. J. (1994) CLUSTAL W: improving 
the sensitivity of progressive multiple sequence alignment through sequence weighting, 
position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22, 4673-4680 
38 Svergun, D. (1992) Determination of the regularization parameter in indirect-
transform methods using perceptual criteria. J. Appl. Crystallogr. 25, 495-503 
39 Konarev, P. V., Volkov, V. V., Sokolova, A. V., Koch, M. H. J. and Svergun, D. I. 
(2003) PRIMUS: a Windows PC-based system for small-angle scattering data analysis. J. 
Appl. Crystallogr. 36, 1277-1282 
40 Franke, D. and Svergun, D. I. (2009) DAMMIF, a program for rapid ab-initio shape 
determination in small-angle scattering. J. Appl. Crystallogr. 42, 342-346 
41 Svergun, D. I., Petoukhov, M. V. and Koch, M. H. (2001) Determination of domain 
structure of proteins from X-ray solution scattering. Biophys. J. 80, 2946-2953 
42 Volkov, V. V. and Svergun, D. I. (2003) Uniqueness of ab initio shape determination 
in small-angle scattering. J. Appl. Crystallogr. 36, 860-864 
43 Schneidman-Duhovny, D., Hammel, M., Tainer, J. A. and Sali, A. (2016) FoXS, 
FoXSDock and MultiFoXS: Single-state and multi-state structural modeling of proteins and 
their complexes based on SAXS profiles. Nucleic Acids Res. 
44 Zhang, Y. (2008) I-TASSER server for protein 3D structure prediction. BMC 
Bioinformatics. 9, 40 
45 Wood, C. W., Bruning, M., Ibarra, A. A., Bartlett, G. J., Thomson, A. R., Sessions, R. 
B., Brady, R. L. and Woolfson, D. N. (2014) CCBuilder: an interactive web-based tool for 
building, designing and assessing coiled-coil protein assemblies. Bioinformatics. 30, 3029-
3035 
46 Holtzer, M. E. and Holtzer, A. (1992) Alpha-helix to random coil transitions: 
interpretation of the CD in the region of linear temperature dependence. Biopolymers. 32, 
1589-1591 
47 Wang, E. and Wang, C. L. (1996) (i, i + 4) Ion pairs stabilize helical peptides derived 
from smooth muscle caldesmon. Arch. Biochem. Biophys. 329, 156-162 
  23 
48 Jayasundar, J. J., Ju, J. H., He, L., Liu, D., Meilleur, F., Zhao, J., Callaway, D. J. and 
Bu, Z. (2012) Open conformation of ezrin bound to phosphatidylinositol 4,5-bisphosphate 
and to F-actin revealed by neutron scattering. J. Biol. Chem. 287, 37119-37133 
49 Cohen, C. and Parry, D. A. D. (1986) Alpha-Helical Coiled Coils - a Widespread 
Motif in Proteins. Trends Biochem. Sci. 11, 245-248 
50 Testa, O. D., Moutevelis, E. and Woolfson, D. N. (2009) CC+: a relational database 
of coiled-coil structures. Nucleic Acids Res. 37, D315-322 
51 Kitano, K., Yusa, F. and Hakoshima, T. (2006) Structure of dimerized radixin FERM 
domain suggests a novel masking motif in C-terminal residues 295-304. Acta Crystallogr. 
Sect. F Struct. Biol. Cryst. Commun. 62, 340-345 
52 Hoeflich, K. P., Tsukita, S., Hicks, L., Kay, C. M. and Ikura, M. (2003) Insights into a 
single rod-like helix in activated radixin required for membrane-cytoskeletal cross-linking. 
Biochemistry. 42, 11634-11641 
53 Ishikawa, H., Tamura, A., Matsui, T., Sasaki, H., Hakoshima, T. and Tsukita, S. 
(2001) Structural conversion between open and closed forms of radixin: low-angle 
shadowing electron microscopy. J. Mol. Biol. 310, 973-978 
54 Liu, D., Ge, L., Wang, F., Takahashi, H., Wang, D., Guo, Z., Yoshimura, S. H., Ward, 
T., Ding, X., Takeyasu, K. and Yao, X. (2007) Single-molecule detection of phosphorylation-
induced plasticity changes during ezrin activation. FEBS Lett. 581, 3563-3571 
55 Chen, V. B., Arendall, W. B., 3rd, Headd, J. J., Keedy, D. A., Immormino, R. M., 
Kapral, G. J., Murray, L. W., Richardson, J. S. and Richardson, D. C. (2010) MolProbity: all-
atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. 
Crystallogr. 66, 12-21 
 
 
 
 
 
  24 
FIGURE LEGENDS 
FIGURE 1. Crystal structure of the ezrin FERM domain and the FERM:C-terminal domain 
complex. A. Cartoon representation of the ezrin FERM domain showing subdomains: F1 
(magenta, residues 2-82), F2 (orange, residues 96-198) and F3 (green, residues 204-296), 
with linker regions in blue.  B. The crystal structure of the ezrin FERM:C-terminal domain 
complex colored as a rainbow from the N-terminus (blue) to the C-terminus (red).  The 
orientation is similar to the FERM domain structure in panel A.  C. Comparison of the three 
independent structures of the ezrin FERM:C-terminal domain complex (4RM8-A: green, 
4RM8-B: purple, 4RM9: orange). D. A superposition of the FERM only structure (yellow) 
with the FERM:C-terminal domain complex (FERM domain: cyan, C-terminal domain: red).  
The panels show close up views of the structural changes in FERM subdomain F3 (E) and F2 
(F). The arrow in panel E indicates movement of the upper -sandwich/β-sheet region in 
subdomain F3.  Note the two close ups are rotated relative to the panel D for clarity. 
FIGURE 2. Structural plasticity in the core of subdomain F3 in the ezrin FERM domain 
structure. A-C. The array of phenylalanine residues in the core of subdomain F3 for the 
FERM only structure (A: molecule A and B: molecule B both shown in green) and the 
FERM:C-terminal domain complex (C) where the FERM domain is shown in cyan and the 
C-terminal domain shown in pink. Molecule A in the FERM domain structure shows two 
alternative conformations of the phenylalanine array (cyan and magenta in A), while the 
other structures show a single conformation (shown in yellow in B and C). Electron density 
is shown as a grey mesh.  D. A cartoon representation of the crystallographic B-factors for 
the FERM domain structure (molecule B). Blue represents 20 Å2 while red represents 50 Å2.  
E,F. The distribution of main chain B-factors for the outer β-sheet of subdomain F3 
(β-strands β5-β7) compared to subdomain F3 and the remainder of the molecule for the ezrin 
FERM domain structure (E) and the FERM:C-terminal domain complex (F). 
FIGURE 3. Circular dichroism spectroscopy and thermal denaturation of ezrin. A. CD 
spectra (n=3) of proteins before (20 °C showing strong features) and after (80 °C showing 
reduced features) thermal denaturation. B. Representative thermal denaturation curves of 
ezrin (FERM domain and full-length ezrin monomer and dimer) measured at 208 nm and 
1 °C/min heating rate, with a sigmoidal function fitted to the data.  
FIGURE 4. SAXS data analysis. A.  Logarithm of the SAXS intensity plotted as a function 
of the magnitude of the scattering vector, Q, for ezrin monomer (grey) overlaid on the ezrin 
dimer (black).  The inset plots the linear difference between the scattering intensity of the 
dimer and monomer samples as a function of Q (the region used to calculated the linear 
difference is shown by the dotted box in A). B. The scattering intensity versus Q plotted on a 
Log-Log scale.  The inset shows the Guinier plots for the monomer (grey) and dimer (black).  
The shaded boxes indicate the data points used to calculate Rg.  Note: the d values on the x-
axis represents the Bragg spacings equivalent to the Q values.  C.  The pair distribution plot 
P(r) for the monomer (grey) and dimer (black). 
FIGURE 5. Modeling the solution structures of ezrin monomer and dimer. A. A panel of 
sixteen ab initio reconstructions derived from the SAXS data for the ezrin monomer. These 
reconstructions have been aligned using the program DAMAVER [42].  B. The homology 
model for the human ezrin monomer overlaid on surfaces representing the averaged (grey) 
and filtered (green) shapes obtained from the ab initio models as calculated by DAMAVER. 
C. A panel of nine ab initio reconstructions derived from the SAXS data for the ezrin dimer. 
These reconstructions have been aligned using the program DAMAVER [42].  D. The 
  25 
homology model for the human ezrin dimer overlaid on surfaces representing the averaged 
(grey) and filtered (green) shapes obtained from the ab initio models as calculated by 
DAMAVER.  Each panel shows the models in two orientations related by a 90° rotation 
about the vertical axis in the plane of the image. 
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Table 1. Crystallographic data and refinement statistics 
 
PDB 
FERM-Ezrin 
4RMA 
Ezrin-1 
4RM9 
Ezrin-2 
4RM8 
A. Data Collection    
Wavelength (Å) 0.954 0.954 0.954 
Space Group P21 C2221 P21 
Unit cell parameters (Å) a=48.3 
b=110.6 
c=66.1 
=101.6° 
a=67.4 
b=113.5 
c=111.8 
===90° 
a=65.0 
b=111.8 
c=68.4 
=113.0° 
Resolution (Å)a 1.75 
(1.84-1.75) 
2.0 
(2.11-2.00) 
1.9 
(2.00-1.90) 
Rmerge (%)a 7.0 (70.1) 11.8 (80.9) 11.2 (34.2) 
Total reflections (Unique) 249580 (66327) 401954 (28759) 242283 (67737) 
<I/(I)> a 10.9 (1.9) 14.1 (3.7) 7.1 (2.0) 
Completeness (%)a 97.0 (94.6) 98.3 (97.7) 95.9 (92.0) 
Multiplicity a 3.8 (3.6) 14.0 (14.4) 3.6 (2.0) 
Wilson B-factor (Å2)b 21.2              
(25.9, 17.9, 13.6) 
24.9 
(41.1, 27.5, 17.9) 
24.4 
(28.1, 26.7, 19.3) 
B. Refinement    
Resolution Range (Å) 35.97-1.75 40.24-2.00 39.40-1.90 
Total number of atoms 
(Protein atoms) 
5437 
(4942) 
3233 
(3086) 
6776 
(6198) 
R-factor  20.0 20.2 17.4 
R-free  24.3 25.3 21.2 
Average B factor (Å2) 32.3 45.8 33.3 
Ramachandran plot (%)c    
    Most favored 98.46% 96.2% 99.2% 
    Outliers 0.2% (Asp252-B) 0.3% (Lys63) 0.1% (Asp252-A) 
RMS bond length (Å)d 0.013 0.003 0.005 
RMS bond anglesd 1.345° 0.736° 0.894° 
MolProbity Clash Score c 4.42 6.29 3.46 
MolProbity Overall Score c 1.49 1.80 1.14 
aPair values correspond to overall and outer shell (in parentheses) statistics 
bValues in parentheses correspond to maximum likelihood-based estimation of overall anisotropic 
Wilson B tensor obtained using phenix.xtriage tool from PHENIX suite [35] 
cValues calculated using MolProbity [55] 
dfrom PHENIX [35] 
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Table 2. SAXS analysis 
 
Ezrin Monomer Ezrin Dimer 
Data   
Q range 0.00531 – 0.954 Å-1 0.00531 – 0.954 Å-1 
D = 2π/Q 1200 – 6.6 Å 1200 – 6.6 Å 
Guinier analysis   
Points in Guinier region (point 
numbers) 
31 (3-33) 8 (2-9) 
QxRg range 0.209 – 0.997 0.537 – 0.933 
Rg (Guinier best fit) 39.4±0.3 Å 91±4 Å 
P(r) analysis   
Qmax used for P(r) 0.5 Å-1 (points 3-375) 0.5 Å-1 (points 2-370) 
Regularization (smoothing) 
parameter ”alpha”† 
1.0 1.0 
Dmax, best estimate, (range) 165 Å (160-175 Å) 325 Å (320-335 Å) 
Rg (P(r)), using best Dmax,  41±1 Å 95±5 Å 
†Smoothing parameter used in GNOM [38] 
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Table 3. Fitting atomic models to SAXS data 
Model Crystal 
Structure 
only† 
Crystal 
structure + 
Coiled-coil 
Crystal 
structure + 
Coiled-coil + 
helix αA‡ 
Crystal 
structure + 
Coiled-coil + 
helix αA + β8§ 
Full 
homology 
model 
Residues 1-297 
516-586 
1-297 
354-467 
516-586 
1-467 
516-586 
1-467 
496-586 
1-586 
Completeness 
of model 
63.1% 82.6% 92.7% 95.6% 100% 
Monomer      
χ value¶ 12.99 4.12 2.26 2.89 3.92 
# atoms 3075 4027 4516 4659 4873 
Dimer      
χ value¶ 10.98 3.19 3.58 3.98 4.45 
# atoms 6150 8054 9032 9318 9746 
†Crystal structure of the ezrin FERM:C-terminal domain complex (4RM8). 
‡FERM domain continuously linked to coiled-coil via helical domain helix αA plus full helix αB. 
§C-terminal domain extended N-terminally so that it starts with the additional β-strand β8 which is 
antiparallel to β-strand β5 in subdomain F3. 
¶χ value calculated by FoXS [43]. 
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